Sanjay H. Mathew, MD
Perelman School of Medicine of the University of Pennsylvania, Philadelphia, Pennsylvania (Thase); Baylor College of Medicine, Houston, Texas
Original Research
Effect of Aripiprazole or rTMS Augmentation Versus Switching to Venlafaxine on Quality of Life
August 11, 2025
Augmentation with aripiprazole, but not rTMS, improved quality of life significantly versus venlafaxine XR/duloxetine switch in patients with treatment-resistant depression.
